Table 3.
The recurrence pattern of re-recurrences in the two treatment groups.
| Recurrence pattern | RFA-Sorafenib | RFA | P-value |
|---|---|---|---|
| First recurrence | 1.000 | ||
| Intrahepatic recurrence | 87 | 98 | |
| Extrahepatic recurrence | 2 | 3 | |
| Intrahepatic recurrence + Extrahepatic recurrence |
1 | 2 | |
| Second recurrence | 1.000 | ||
| Intrahepatic recurrence | 18 | 18 | |
| Extrahepatic recurrence | 1 | 0 | |
| Intrahepatic recurrence + Extrahepatic recurrence |
2 | 2 | |
| Third recurrence | 0.682 | ||
| Intrahepatic recurrence | 6 | 3 | |
| Extrahepatic recurrence | 1 | 1 | |
| Intrahepatic recurrence + Extrahepatic recurrence |
0 | 1 |
RFA, radiofrequency ablation.